163 related articles for article (PubMed ID: 29236213)
21. Interactions of selected indole derivatives with COX-2 and their in silico structure modifications towards the development of novel NSAIDs.
Dileep KV; Remya C; Tintu I; Sadasivan C
J Biomol Struct Dyn; 2014; 32(11):1855-63. PubMed ID: 24053423
[TBL] [Abstract][Full Text] [Related]
22. Quantifying intrinsic specificity: a potential complement to affinity in drug screening.
Wang J; Zheng X; Yang Y; Drueckhammer D; Yang W; Verkhivker G; Wang E
Phys Rev Lett; 2007 Nov; 99(19):198101. PubMed ID: 18233118
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of new ibuprofen derivatives with their in silico and in vitro cyclooxygenase-2 inhibitions.
Gundogdu-Hizliates C; Alyuruk H; Gocmenturk M; Ergun Y; Cavas L
Bioorg Chem; 2014 Feb; 52():8-15. PubMed ID: 24270352
[TBL] [Abstract][Full Text] [Related]
24. Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity.
Coy-Barrera E
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 31979339
[TBL] [Abstract][Full Text] [Related]
25. Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: implications in drug designing and development.
Singh S; Pandey VP; Naaz H; Singh P; Dwivedi UN
Comput Biol Med; 2013 Jul; 43(6):744-50. PubMed ID: 23668350
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
27. Precise cuts for tailoring chromene-phenyl COX inhibitors with Ligand Designer.
Vo HHN; Phung THT; Chung KL; Vu TY
J Mol Graph Model; 2024 Jun; 129():108747. PubMed ID: 38447296
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
[TBL] [Abstract][Full Text] [Related]
29. QSAR modeling, pharmacophore-based virtual screening, and ensemble docking insights into predicting potential epigallocatechin gallate (EGCG) analogs against epidermal growth factor receptor.
Bommu UD; Konidala KK; Pabbaraju N; Yeguvapalli S
J Recept Signal Transduct Res; 2019 Feb; 39(1):18-27. PubMed ID: 31223050
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of [(125)I]Pyricoxib: A novel (125)I-labeled cyclooxygenase-2 (COX-2) inhibitors.
Tietz O; Dzandzi J; Bhardwaj A; Valliant JF; Wuest F
Bioorg Med Chem Lett; 2016 Mar; 26(6):1516-1520. PubMed ID: 26898334
[TBL] [Abstract][Full Text] [Related]
31. Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2.
Al-Suwaidan IA; Alanazi AM; El-Azab AS; Al-Obaid AM; ElTahir KE; Maarouf AR; Abu El-Enin MA; Abdel-Aziz AA
Bioorg Med Chem Lett; 2013 May; 23(9):2601-5. PubMed ID: 23528298
[TBL] [Abstract][Full Text] [Related]
32. Discovery of Novel 2-Amino-5-(Substituted)-1,3,4-Thiadiazole Derivatives: New Utilities for Colon Cancer Treatment.
Raj V; Rai A; Singh AK; Keshari AK; Trivedi P; Ghosh B; Kumar U; Kumar D; Saha S
Anticancer Agents Med Chem; 2018; 18(5):719-738. PubMed ID: 28425852
[TBL] [Abstract][Full Text] [Related]
33. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.
Tugcu G; Sipahi H; Aydin A
Curr Top Med Chem; 2019; 19(13):1121-1128. PubMed ID: 31210111
[TBL] [Abstract][Full Text] [Related]
34. A Practical Perspective: The Effect of Ligand Conformers on the Negative Image-Based Screening.
Ahinko M; Kurkinen ST; Niinivehmas SP; Pentikäinen OT; Postila PA
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174295
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors.
Khanna S; Madan M; Vangoori A; Banerjee R; Thaimattam R; Jafar Sadik Basha SK; Ramesh M; Casturi SR; Pal M
Bioorg Med Chem; 2006 Jul; 14(14):4820-33. PubMed ID: 16581252
[TBL] [Abstract][Full Text] [Related]
36. In situ click chemistry generation of cyclooxygenase-2 inhibitors.
Bhardwaj A; Kaur J; Wuest M; Wuest F
Nat Commun; 2017 Feb; 8(1):1. PubMed ID: 28232747
[TBL] [Abstract][Full Text] [Related]
37. Discovery of andrographolide hit analog as a potent cyclooxygenase-2 inhibitor through consensus MD-simulation, electrostatic potential energy simulation and ligand efficiency metrics.
Jain P; Satija J; Sudandiradoss C
Sci Rep; 2023 May; 13(1):8147. PubMed ID: 37208387
[TBL] [Abstract][Full Text] [Related]
38. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
39. Molecular Docking and
Shah K; Mujwar S; Gupta JK; Shrivastava SK; Mishra P
Assay Drug Dev Technol; 2019 Aug; 17(6):285-291. PubMed ID: 31532713
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors.
Hassanein HH; Georgey HH; Fouad MA; El Kerdawy AM; Said MF
Future Med Chem; 2017 Apr; 9(6):553-578. PubMed ID: 28394629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]